
Therapeutic cancer vaccines: Why so few randomised phase III studies reflect the initial optimism of phase II studies
Keywords: انتخاب بیمار; Cancer vaccines; Phase 2 trials; Phase 3 trials; Need for biomarkers; Patient selection; Inflammation;